the valuation exercise, page-28

groins, thanks

but please don't groan..

go back to my post on the cost of cancer in the US - posted over the weekend - it will give you a good intro to how the US govt's pharma scheme places and subsidises cancer drugs at the top of the list (presently, anyway) - ie, cancer is subsidised in the US

as for women as being a priority in US health - go look how many more women voted last election, and how active for the past three decades they have been on women's issues - you know, like the US abortion debate - gets airtime, gets votes... gets prioritised, especially when there is no other drug out there to help them with ovarian cancer - sought like our prostate deal.. sought of like Dendreon..

as for a 'hitch' with Dendreon.. mate.. newbie?.. what the hell do you think 3 phases of trials are all about, before the final FDA trialling and approval, where we may jump the last hoop too - please, get with the no-hitches science of the program

and if you don't like comparisons, OK - what else in terms of 'the science' have you got for us groins?

and as an aside... if it is a Microsoft/Google deal, we'll probably end up being on the google side of that pretty picture (hopefully, maybe)

charts - comparisons - and asking a hell load more questions is what it is about..

i do appreciate your thoughts groins, they help me focus the right issues, and look for proper data points

and yes, i'm enjoying my wine tonight.. red by the way



good luck